The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis

Anne Bellemain-Appaix (1) , Céline Bégué , Deepak Bhatt (2) , Kenneth Ducci , Robert Harrington , Matthew Roe , Stephen Wiviott (3) , Michel Cucherat (4) , Johanne Silvain (5) , Jean-Philippe Collet (5) , François Bernasconi , Gilles Montalescot (6)

1 Service de cardiologie
2 VA Boston Healthcare System
3 BWH - Brigham & Women’s Hospital [Boston]
4 Evaluation et modélisation des effets thérapeutiques
5 ICAN - Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition
6 Génomique cardiovasculaire

Domains: Life Sciences [q-bio]; Pharmaceutical sciences; Pharmacology

Anne Bellemain-Appaix, Céline Bégué, Deepak Bhatt, Kenneth Ducci, Robert Harrington, et al.. The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis. EuroIntervention , 2018, 14 (1), pp.78-85. ⟨10.4244/EIJ-D-17-00852⟩. ⟨hal-02112950⟩